Tenaci-T Therapeutics LLC
Missouri City, TX
- UEI
- MTRTYVL8N717
- CAGE
- 01U66
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 8911 Forest Side Dr, Missouri City, TX 77459, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$55,000 |
| FY2025 | $352,621 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FY2025 sbir concept clearance award for topic development of therapeutic or preventative technologies for treatment… | National Cancer Institute (NIH) | $297,621 |
Quick answers
Is Tenaci-T Therapeutics LLC registered in SAM.gov?
Yes. Tenaci-T Therapeutics LLC's SAM.gov registration is active through June 3, 2027.
What is Tenaci-T Therapeutics LLC's CAGE code?
Tenaci-T Therapeutics LLC's CAGE code is 01U66, and its Unique Entity ID (UEI) is MTRTYVL8N717.
How much has Tenaci-T Therapeutics LLC received in federal contracts?
Federal contracts obligated $352,621 to Tenaci-T Therapeutics LLC in fiscal year 2025 and $297,621 in fiscal years 2023 through 2027.
What is Tenaci-T Therapeutics LLC's most recent federal award?
Tenaci-T Therapeutics LLC's most recent federal contract award is FY2025 sbir concept clearance award for topic development of therapeutic or preventative technologies for treatment… (75N91025C00012), from National Cancer Institute (NIH), on September 17, 2025.
On GovTribe
See Tenaci-T Therapeutics LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors